Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CFTR | P13569 | 7/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | MAPT | P10636 | 3/20 | 0.36 |
| ▸ | HPGD | P15428 | 3/20 | 0.36 |
| ▸ | GAA | P10253 | 2/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | GLA | P06280 | 1/20 | 0.35 |
| ▸ | CASP1 | P29466 | 1/20 | 0.35 |
| ▸ | CASP7 | P55210 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | ABL1 | P00519 | 1/20 | 0.35 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4628796 | 0.84 | CFTR (0.56) | CFTRKDM4EALDH1A1MAPTHPGD | |
| SCHEMBL4628821 | 0.84 | CFTR (0.53) | CFTRKDM4EALDH1A1MAPTHPGD | |
| SCHEMBL4627735 | 0.83 | CFTR (0.60) | CFTRKDM4EALDH1A1MAPTHPGD | |
| SCHEMBL4627860 | 0.79 | CFTR (0.55) | CFTRKDM4EALDH1A1MAPTHPGD | |
| SCHEMBL2391555 | 0.78 | CFTR (0.56) | CFTRKDM4EALDH1A1HPGDGAA | |
| SCHEMBL9942844 | 0.77 | CFTR (0.63) | CFTRKDM4EALDH1A1MAPTHPGD | |
| SCHEMBL2391646 | 0.73 | CFTR (0.60) | CFTRKDM4EALDH1A1MAPTHPGD | |
| SCHEMBL2389934 | 0.72 | CFTR (0.63) | CFTRKDM4EALDH1A1MAPTHPGD | |
| SCHEMBL2390188 | 0.72 | CFTR (0.53) | CFTRKDM4EALDH1A1MAPTHPGD | |
| SCHEMBL22833377 | 0.71 | CFTR (0.70) | CFTRKDM4EALDH1A1MAPTHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1871749-A1 | 1H-QUINAZ0LINE-2,4-DIONES AND THEIR USE AS AMPA-RECEPTOR LIGANDS | Novartis AG (US) | 2008-01-02 | — | — | EP | disclosed |
| WO-2006108591-A1 | 1H-QUINAZ0LINE-2,4-DIONES AND THEIR USE AS AMPA-RECEPTOR LIGANDS | NOVARTIS AG (CH) | 2006-10-19 | — | — | WO | disclosed |